journal article·2015-03-18

Silylated Precision Particles for Controlled Release of Proteins

Khosrow Khodabandehlou, Amar S. Kumbhar, Sohrab Habibi, Ashish A. Pandya, J. Christopher Luft, Saad A. Khan, Joseph M. DeSimone

Publisher page

Abstract

With the recent advances in the development of novel protein based therapeutics, controlled delivery of these biologics is an important area of research. Herein, we report the synthesis of microparticles from bovine serum albumin (BSA) as a model protein using Particle Replication in Non-wetting Templates (PRINT) with specific size and shape. These particles were functionalized at room temperature using multifunctional chlorosilane that cross-link the particles to render them to slowly-dissolving in aqueous media. Mass spectrometric study of the reaction products of diisopropyldichlorosilane with individual components of the particles revealed that they are capable of reacting and forming cross-links. Energy dispersive spectroscopy (EDS) and X-ray photoelectron spectroscopy (XPS) were also used to confirm the functionalization of the particles. Cross sectional analysis using focused ion beam (FIB) and EDS proved that the functionalization occurs throughout the bulk of the particles and is not just limited to the surface. Circular dichroism data confirmed that the fraction of BSA molecules released from the particles retains its secondary structure thereby indicating that the system can be used for delivering protein based formulations while controlling the dissolution kinetics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Protein purification and stability · Microfluidic and Capillary Electrophoresis Applications · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina 27695, United States

Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, United States

Funding

Liquidia Technologies · National Institutes of Health

References (70)

Show source-provided references
1. Almeida A. J. · Adv. Drug Delivery Rev. · 2007 · 59 · 47810.1016/j.addr.2007.04.007 ↗
2. Harn N. · J. Pharm. Sci. · 2007 · 96 · 53210.1002/jps.20753 ↗
3. Antosova Z. · Trends Biotechnol. · 2009 · 27 · 62810.1016/j.tibtech.2009.07.009 ↗
4. Vermonden T. · Chem. Rev. · 2012 · 112 · 285310.1021/cr200157d ↗
5. Manning M. C. · Pharm. Res. · 2010 · 27 · 54410.1007/s11095-009-0045-6 ↗
6. Pechenov S. · J. Controlled Release · 2004 · 96 · 14910.1016/j.jconrel.2004.01.019 ↗
7. Lee, V. H. L.; Dodda-Kashi, S.; Grass, G. M.; Rubas, W.InPeptide and Protein Drug Delivery;Lee, V. H. L., Ed.Marcel Dekker:New York, NY, 1991; Chapter 16, pp691–738.10.1201/9781003573715-18 ↗
8. Brown L. R. · Expert Opin. Drug Delivery · 2005 · 2 · 2910.1517/17425247.2.1.29 ↗
9. Riva P. · Int. J. Cancer · 1992 · 51 · 710.1002/ijc.2910510103 ↗
10. Kitamura K. · Cancer Res. · 1992 · 52 · 6323
11. Abrishami M. · Retina · 2009 · 29 · 69910.1097/IAE.0b013e3181a2f42a ↗
12. Ohtori S. · Eur. Spine J. · 2012 · 21 · 207910.1007/s00586-012-2183-5 ↗
13. Nikas S. · Ann. Rheum. Dis. · 2004 · 63 · 10210.1136/ard.2003.006981 ↗
14. Jorgensen L. · 200910.1002/9780470688397 ↗
15. Banerjee, P. S.; Hosny, E. A.; Robinson, J. R.InPeptide and Protein Drug Delivery;Lee, V. H. L., Ed.Marcel Dekker:New York, NY, 1991; Chapter 10, pp487–543.
16. Lee K. Y. · Prog. Polym. Sci. · 2007 · 32 · 66910.1016/j.progpolymsci.2007.04.001 ↗
17. Yang M. X. · Proc. Natl. Acad. Sci. U.S.A. · 2003 · 100 · 693410.1073/pnas.1131899100 ↗
18. Miller M. A. · Langmuir · 2010 · 26 · 106710.1021/la9023426 ↗
19. Arshady R. · J. Controlled Release · 1990 · 14 · 11110.1016/0168-3659(90)90149-N ↗
20. Patil G. V. · Drug Dev. Res. · 2003 · 58 · 21910.1002/ddr.10157 ↗
21. Tong W. · Colloid Polym. Sci. · 2008 · 286 · 110310.1007/s00396-008-1885-z ↗
22. Zhou Z. · Adv. Mater. · 2013 · 25 · 272310.1002/adma.201300220 ↗
23. Nettey H. · J. Microencapsulation · 2006 · 23 · 63210.1080/02652040600776564 ↗
24. Langer K. · Int. J. Pharm. · 2003 · 257 · 16910.1016/S0378-5173(03)00134-0 ↗
25. Lin W. · J. Drug Targeting · 1993 · 1 · 23710.3109/10611869308996081 ↗
26. Bogdansky, S.InBiodegradable Polymers as Drug Delivery Systems;Chasin, M.; Langer, R., Eds.Marcel Dekker:New York, NY, 1990; Chapter 7, pp231–259.
27. Bhargava K. · Pharm. Res. · 1992 · 9 · 77610.1023/A:1015855622459 ↗
28. Goosen M. F. · Diabetes · 1983 · 32 · 47810.2337/diab.32.5.478 ↗
29. Rollett A. · Int. J. Pharm. · 2012 · 427 · 46010.1016/j.ijpharm.2012.02.028 ↗
30. Oettinger C. W. · J. Microencapsulation · 2012 · 29 · 45510.3109/02652048.2012.658443 ↗
31. Kratz F. · J. Controlled Release · 2008 · 132 · 17110.1016/j.jconrel.2008.05.010 ↗
32. Doshi N. · PLoS One · 2010 · 5 · e1005110.1371/journal.pone.0010051 ↗
33. Lee T. K. · Science · 1981 · 213 · 23310.1126/science.6787705 ↗
34. Ratcliffe J. H. · J. Pharm. Pharmacol. · 1984 · 36 · 43110.1111/j.2042-7158.1984.tb04419.x ↗
35. Wong S. S. · 1991
36. Srinivasachar K. · Biochemistry · 1989 · 28 · 250110.1021/bi00432a023 ↗
37. Benesch R. E. · Biochem. Biophys. Res. Commun. · 1988 · 156 · 910.1016/S0006-291X(88)80798-8 ↗
38. Blattler W. A. · Biochemistry · 1985 · 24 · 151710.1021/bi00327a034 ↗
39. Parrott M. C. · J. Am. Chem. Soc. · 2010 · 132 · 1792810.1021/ja108568g ↗
40. Kelly J. Y. · J. Am. Chem. Soc. · 2008 · 130 · 543810.1021/ja8014428 ↗
41. Houen G. · Acta Chem. Scand. · 1996 · 50 · 6810.3891/acta.chem.scand.50-0068 ↗
42. Griebenow K. · J. Am. Chem. Soc. · 1996 · 118 · 1169510.1021/ja961869d ↗
43. Spahr P. · J. Biol. Chem. · 1964 · 239 · 85010.1016/S0021-9258(18)51668-9 ↗
44. Brown J. R. · Fed. Proc. · 1975 · 34 · 591
45. Kolthoff I. M. · J. Am. Chem. Soc. · 1961 · 83 · 392710.1021/ja01480a001 ↗
46. Schneider C. A. · Nat. Methods · 2012 · 9 · 67110.1038/nmeth.2089 ↗
47. Sreerama N. · Anal. Biochem. · 2000 · 287 · 25210.1006/abio.2000.4880 ↗
48. Kashutina M. V. · Russ. Chem. Rev. · 1975 · 44 · 73310.1070/RC1975v044n09ABEH002373 ↗
49. Rogozhin S. V. · Bull. Acad. Sci. USSR, Div. Chem. Sci. (Engl. Transl.) · 1974 · 23 · 178910.1007/BF00923213 ↗
50. Vast L. · Compos. Sci. Technol. · 2007 · 67 · 88010.1016/j.compscitech.2005.12.033 ↗
51. Gousse C. · Polymer · 2002 · 43 · 264510.1016/S0032-3861(02)00051-4 ↗
52. Parrott M. C. · J. Am. Chem. Soc. · 2012 · 134 · 797810.1021/ja301710z ↗
53. Folkes, D. J.; Jordan, M. A.InCarbohydrates in Food;Eliasson, A. C., Ed.Taylor & Francis:Boca Raton, FL, 2006; Chapter 1, pp1–40.
54. Puglisi O. · J. Non-Cryst. Solids · 1984 · 68 · 21910.1016/0022-3093(84)90005-X ↗
55. Lopez G. P. · Surf. Interface Anal. · 1991 · 17 · 26710.1002/sia.740170508 ↗
56. Iucci G. · Surf. Interface Anal. · 2004 · 36 · 72410.1002/sia.1747 ↗
57. Arifin D. Y. · Adv. Drug Delivery Rev. · 2006 · 58 · 127410.1016/j.addr.2006.09.007 ↗
58. Costa P. · Eur. J. Pharm. Sci. · 2001 · 13 · 12310.1016/S0928-0987(01)00095-1 ↗
59. Weibull W. · J. Appl. Mech. · 1951 · 18 · 29310.1115/1.4010337 ↗
60. Korsmeyer R. W. · Int. J. Pharm. · 1983 · 15 · 2510.1016/0378-5173(83)90064-9 ↗
61. Ritger P. L. · J. Controlled Release · 1987 · 5 · 3710.1016/0168-3659(87)90035-6 ↗
62. Shirai N. · Tetrahedron · 1986 · 42 · 221110.1016/S0040-4020(01)90600-3 ↗
63. Houen G. · Acta Chem. Scand. · 1999 · 53 · 112210.3891/acta.chem.scand.53-1122 ↗
64. Nakagaki M. · Bull. Chem. Soc. Jpn. · 1973 · 46 · 79110.1246/bcsj.46.791 ↗
65. Estey T. · J. Pharm. Sci. · 2006 · 95 · 162610.1002/jps.20625 ↗
66. Rosenberg A. S. · AAPS J. · 2006 · 8 · E50110.1208/aapsj080359 ↗
67. Carpenter J. F. · J. Pharm. Sci. · 2009 · 98 · 120110.1002/jps.21530 ↗
68. Singh S. K. · J. Pharm. Sci. · 2010 · 99 · 330210.1002/jps.22097 ↗
69. van Beers M. M. · Pharm. Res. · 2011 · 28 · 239310.1007/s11095-011-0451-4 ↗
70. Hermeling S. · Pharm. Res. · 2005 · 22 · 199710.1007/s11095-005-8177-9 ↗